Global Tardive Dyskinesia (TD) Treatment Drugs Market Research Report 2024(Status and Outlook)
Report Overview
Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive dyskinesia is difficult to treat as treatment process is also not confirmed and the drug is also not approved in various conditions. The treatment of tardive dyskinesia is directly affect the neurological system of the respective patients. This disorder may commonly occurs in smoker than non-smoker, and also in the patient of depression, anxiety disorder and others.
This report provides a deep insight into the global Tardive Dyskinesia (TD) Treatment Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tardive Dyskinesia (TD) Treatment Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tardive Dyskinesia (TD) Treatment Drugs market in any manner.
Global Tardive Dyskinesia (TD) Treatment Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries
Pfizer Inc.
Biogen
Novartis AG
AstraZeneca
GlaxoSmithKline plc.
Bayer AG
Sanofi
Market Segmentation (by Type)
Valbenazine
Deutetrabenazine
Market Segmentation (by Application)
Hospitals
Clinic
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tardive Dyskinesia (TD) Treatment Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive dyskinesia is difficult to treat as treatment process is also not confirmed and the drug is also not approved in various conditions. The treatment of tardive dyskinesia is directly affect the neurological system of the respective patients. This disorder may commonly occurs in smoker than non-smoker, and also in the patient of depression, anxiety disorder and others.
This report provides a deep insight into the global Tardive Dyskinesia (TD) Treatment Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tardive Dyskinesia (TD) Treatment Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tardive Dyskinesia (TD) Treatment Drugs market in any manner.
Global Tardive Dyskinesia (TD) Treatment Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries
Pfizer Inc.
Biogen
Novartis AG
AstraZeneca
GlaxoSmithKline plc.
Bayer AG
Sanofi
Market Segmentation (by Type)
Valbenazine
Deutetrabenazine
Market Segmentation (by Application)
Hospitals
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Tardive Dyskinesia (TD) Treatment Drugs Market
- Overview of the regional outlook of the Tardive Dyskinesia (TD) Treatment Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tardive Dyskinesia (TD) Treatment Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Tardive Dyskinesia (TD) Treatment Drugs
1.2 Key Market Segments
1.2.1 Tardive Dyskinesia (TD) Treatment Drugs Segment by Type
1.2.2 Tardive Dyskinesia (TD) Treatment Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Manufacturers (2019-2024)
3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Tardive Dyskinesia (TD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tardive Dyskinesia (TD) Treatment Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tardive Dyskinesia (TD) Treatment Drugs Sales Sites, Area Served, Product Type
3.6 Tardive Dyskinesia (TD) Treatment Drugs Market Competitive Situation and Trends
3.6.1 Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tardive Dyskinesia (TD) Treatment Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Tardive Dyskinesia (TD) Treatment Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Type (2019-2024)
6.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Tardive Dyskinesia (TD) Treatment Drugs Price by Type (2019-2024)
7 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Sales by Application (2019-2024)
7.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Tardive Dyskinesia (TD) Treatment Drugs Sales Growth Rate by Application (2019-2024)
8 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Region
8.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Region
8.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Tardive Dyskinesia (TD) Treatment Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tardive Dyskinesia (TD) Treatment Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Neurocrine Biosciences, Inc.
9.1.1 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.1.2 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.1.4 Neurocrine Biosciences, Inc. Business Overview
9.1.5 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
9.1.6 Neurocrine Biosciences, Inc. Recent Developments
9.2 Teva Pharmaceutical Industries
9.2.1 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.2.2 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.2.4 Teva Pharmaceutical Industries Business Overview
9.2.5 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
9.2.6 Teva Pharmaceutical Industries Recent Developments
9.3 Pfizer Inc.
9.3.1 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.3.2 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.3.4 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
9.3.5 Pfizer Inc. Business Overview
9.3.6 Pfizer Inc. Recent Developments
9.4 Biogen
9.4.1 Biogen Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.4.2 Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.4.4 Biogen Business Overview
9.4.5 Biogen Recent Developments
9.5 Novartis AG
9.5.1 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.5.2 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.5.4 Novartis AG Business Overview
9.5.5 Novartis AG Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.6.2 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 GlaxoSmithKline plc.
9.7.1 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.7.2 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.7.4 GlaxoSmithKline plc. Business Overview
9.7.5 GlaxoSmithKline plc. Recent Developments
9.8 Bayer AG
9.8.1 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.8.2 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.8.4 Bayer AG Business Overview
9.8.5 Bayer AG Recent Developments
9.9 Sanofi
9.9.1 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.9.2 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.9.4 Sanofi Business Overview
9.9.5 Sanofi Recent Developments
10 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET FORECAST BY REGION
10.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast
10.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Region
10.2.4 South America Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tardive Dyskinesia (TD) Treatment Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tardive Dyskinesia (TD) Treatment Drugs by Type (2025-2030)
11.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tardive Dyskinesia (TD) Treatment Drugs by Type (2025-2030)
11.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Tardive Dyskinesia (TD) Treatment Drugs
1.2 Key Market Segments
1.2.1 Tardive Dyskinesia (TD) Treatment Drugs Segment by Type
1.2.2 Tardive Dyskinesia (TD) Treatment Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Manufacturers (2019-2024)
3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Tardive Dyskinesia (TD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tardive Dyskinesia (TD) Treatment Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tardive Dyskinesia (TD) Treatment Drugs Sales Sites, Area Served, Product Type
3.6 Tardive Dyskinesia (TD) Treatment Drugs Market Competitive Situation and Trends
3.6.1 Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tardive Dyskinesia (TD) Treatment Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Tardive Dyskinesia (TD) Treatment Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Type (2019-2024)
6.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Tardive Dyskinesia (TD) Treatment Drugs Price by Type (2019-2024)
7 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Sales by Application (2019-2024)
7.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Tardive Dyskinesia (TD) Treatment Drugs Sales Growth Rate by Application (2019-2024)
8 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Region
8.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Region
8.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Tardive Dyskinesia (TD) Treatment Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tardive Dyskinesia (TD) Treatment Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Neurocrine Biosciences, Inc.
9.1.1 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.1.2 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.1.4 Neurocrine Biosciences, Inc. Business Overview
9.1.5 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
9.1.6 Neurocrine Biosciences, Inc. Recent Developments
9.2 Teva Pharmaceutical Industries
9.2.1 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.2.2 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.2.4 Teva Pharmaceutical Industries Business Overview
9.2.5 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
9.2.6 Teva Pharmaceutical Industries Recent Developments
9.3 Pfizer Inc.
9.3.1 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.3.2 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.3.4 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
9.3.5 Pfizer Inc. Business Overview
9.3.6 Pfizer Inc. Recent Developments
9.4 Biogen
9.4.1 Biogen Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.4.2 Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.4.4 Biogen Business Overview
9.4.5 Biogen Recent Developments
9.5 Novartis AG
9.5.1 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.5.2 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.5.4 Novartis AG Business Overview
9.5.5 Novartis AG Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.6.2 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 GlaxoSmithKline plc.
9.7.1 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.7.2 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.7.4 GlaxoSmithKline plc. Business Overview
9.7.5 GlaxoSmithKline plc. Recent Developments
9.8 Bayer AG
9.8.1 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.8.2 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.8.4 Bayer AG Business Overview
9.8.5 Bayer AG Recent Developments
9.9 Sanofi
9.9.1 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Basic Information
9.9.2 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Overview
9.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Market Performance
9.9.4 Sanofi Business Overview
9.9.5 Sanofi Recent Developments
10 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET FORECAST BY REGION
10.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast
10.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Region
10.2.4 South America Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tardive Dyskinesia (TD) Treatment Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tardive Dyskinesia (TD) Treatment Drugs by Type (2025-2030)
11.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tardive Dyskinesia (TD) Treatment Drugs by Type (2025-2030)
11.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tardive Dyskinesia (TD) Treatment Drugs Market Size Comparison by Region (M USD)
Table 5. Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2022)
Table 10. Global Market Tardive Dyskinesia (TD) Treatment Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tardive Dyskinesia (TD) Treatment Drugs Sales Sites and Area Served
Table 12. Manufacturers Tardive Dyskinesia (TD) Treatment Drugs Product Type
Table 13. Global Tardive Dyskinesia (TD) Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tardive Dyskinesia (TD) Treatment Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tardive Dyskinesia (TD) Treatment Drugs Market Challenges
Table 22. Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Type (Kilotons)
Table 23. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (M USD)
Table 24. Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Type (2019-2024)
Table 28. Global Tardive Dyskinesia (TD) Treatment Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) by Application
Table 30. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
Table 31. Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2024)
Table 35. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Tardive Dyskinesia (TD) Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Tardive Dyskinesia (TD) Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Tardive Dyskinesia (TD) Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 44. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 45. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Neurocrine Biosciences, Inc. Business Overview
Table 47. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
Table 48. Neurocrine Biosciences, Inc. Recent Developments
Table 49. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 50. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 51. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Teva Pharmaceutical Industries Business Overview
Table 53. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
Table 54. Teva Pharmaceutical Industries Recent Developments
Table 55. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 56. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 57. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
Table 59. Pfizer Inc. Business Overview
Table 60. Pfizer Inc. Recent Developments
Table 61. Biogen Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 62. Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 63. Biogen Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Biogen Business Overview
Table 65. Biogen Recent Developments
Table 66. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 67. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 68. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Recent Developments
Table 71. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 72. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 73. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 77. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 78. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. GlaxoSmithKline plc. Business Overview
Table 80. GlaxoSmithKline plc. Recent Developments
Table 81. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 82. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 83. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bayer AG Business Overview
Table 85. Bayer AG Recent Developments
Table 86. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 87. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 88. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sanofi Business Overview
Table 90. Sanofi Recent Developments
Table 91. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Tardive Dyskinesia (TD) Treatment Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tardive Dyskinesia (TD) Treatment Drugs Market Size Comparison by Region (M USD)
Table 5. Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2022)
Table 10. Global Market Tardive Dyskinesia (TD) Treatment Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tardive Dyskinesia (TD) Treatment Drugs Sales Sites and Area Served
Table 12. Manufacturers Tardive Dyskinesia (TD) Treatment Drugs Product Type
Table 13. Global Tardive Dyskinesia (TD) Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tardive Dyskinesia (TD) Treatment Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tardive Dyskinesia (TD) Treatment Drugs Market Challenges
Table 22. Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Type (Kilotons)
Table 23. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (M USD)
Table 24. Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Type (2019-2024)
Table 28. Global Tardive Dyskinesia (TD) Treatment Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) by Application
Table 30. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
Table 31. Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2024)
Table 35. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Tardive Dyskinesia (TD) Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Tardive Dyskinesia (TD) Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Tardive Dyskinesia (TD) Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Tardive Dyskinesia (TD) Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 44. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 45. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Neurocrine Biosciences, Inc. Business Overview
Table 47. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
Table 48. Neurocrine Biosciences, Inc. Recent Developments
Table 49. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 50. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 51. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Teva Pharmaceutical Industries Business Overview
Table 53. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
Table 54. Teva Pharmaceutical Industries Recent Developments
Table 55. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 56. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 57. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs SWOT Analysis
Table 59. Pfizer Inc. Business Overview
Table 60. Pfizer Inc. Recent Developments
Table 61. Biogen Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 62. Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 63. Biogen Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Biogen Business Overview
Table 65. Biogen Recent Developments
Table 66. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 67. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 68. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Recent Developments
Table 71. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 72. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 73. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 77. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 78. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. GlaxoSmithKline plc. Business Overview
Table 80. GlaxoSmithKline plc. Recent Developments
Table 81. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 82. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 83. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bayer AG Business Overview
Table 85. Bayer AG Recent Developments
Table 86. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Basic Information
Table 87. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Overview
Table 88. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sanofi Business Overview
Table 90. Sanofi Recent Developments
Table 91. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Tardive Dyskinesia (TD) Treatment Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Tardive Dyskinesia (TD) Treatment Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD), 2019-2030
Figure 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (M USD)
Figure 11. Tardive Dyskinesia (TD) Treatment Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Manufacturers in 2023
Figure 13. Tardive Dyskinesia (TD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tardive Dyskinesia (TD) Treatment Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type
Figure 18. Sales Market Share of Tardive Dyskinesia (TD) Treatment Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Tardive Dyskinesia (TD) Treatment Drugs by Type in 2023
Figure 20. Market Size Share of Tardive Dyskinesia (TD) Treatment Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Tardive Dyskinesia (TD) Treatment Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application
Figure 24. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Application in 2023
Figure 26. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2024)
Figure 27. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application in 2023
Figure 28. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Tardive Dyskinesia (TD) Treatment Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Country in 2023
Figure 37. Germany Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Region in 2023
Figure 44. China Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Tardive Dyskinesia (TD) Treatment Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD), 2019-2030
Figure 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (M USD)
Figure 11. Tardive Dyskinesia (TD) Treatment Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Manufacturers in 2023
Figure 13. Tardive Dyskinesia (TD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tardive Dyskinesia (TD) Treatment Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type
Figure 18. Sales Market Share of Tardive Dyskinesia (TD) Treatment Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Tardive Dyskinesia (TD) Treatment Drugs by Type in 2023
Figure 20. Market Size Share of Tardive Dyskinesia (TD) Treatment Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Tardive Dyskinesia (TD) Treatment Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application
Figure 24. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Application in 2023
Figure 26. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2024)
Figure 27. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application in 2023
Figure 28. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Tardive Dyskinesia (TD) Treatment Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Tardive Dyskinesia (TD) Treatment Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Country in 2023
Figure 37. Germany Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Region in 2023
Figure 44. China Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Tardive Dyskinesia (TD) Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Tardive Dyskinesia (TD) Treatment Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share Forecast by Application (2025-2030)
